ISSN - Footer
ISSN 2363-202X
Navigation
Skip to Content
Vacunas contra la COVID-19
DisplayLogo
Publications Office of the European Union
MainSearch
Select
All collections
EU law
EU publications
EU official directory
Editorial Content
Summaries of Legislation
More
Advanced search
Browse by subject
Expert Search
Language Selector
български (bg)
español (es)
čeština (cs)
dansk (da)
Deutsch (de)
eesti keel (et)
Ελληνικά (el)
English (en)
français (fr)
Gaeilge (ga)
hrvatski (hr)
italiano (it)
latviešu valoda (lv)
lietuvių kalba (lt)
magyar (hu)
Malti (mt)
Nederlands (nl)
polski (pl)
português (pt)
română (ro)
slovenčina (sk)
slovenščina (sl)
suomi (fi)
svenska (sv)
BasketSummary
0
X
Basket
x
items
X
This item has been added.
Qty:
x
€
x
Sub-total
€
x
Total
€
0.0
View basket
Checkout
MyPortal
Sign in
Navigation Menu
LAW
EU PUBLICATIONS
RESEARCH AND INNOVATION
OPEN DATA
PUBLIC PROCUREMENT
EU WHOISWHO
Navigation Menu
LAW
EU PUBLICATIONS
RESEARCH AND INNOVATION
OPEN DATA
PUBLIC PROCUREMENT
EU WHOISWHO
Publications Office of the EU
Help
Navigation Menu
Breadcrumb
Publication detail
Navigation Menu
AccessibilityTools
Maintenance EN
Please note that this website will be undergoing technical maintenance between 28 and 31 August. Consequently, users may experience instabilities and limited functionality. We apologise for the inconvenience.
Web Content Display (Global)
For a better user experience please update your browser or use
Chrome
or
Firefox
browser.
×
Publication Detail Actions Portlet
Utilities
Add to my publications
Create alert
Permanent link
Metadata RDF
(Opens New Window)
(Opens New Window)
Embed in website
More
Cancel
Rate this publication
custom-survey-notification
We would like to hear your views on this material or activity.
Please click here to provide your feedback.
Publication Detail Portlet
Publication detail
Home
EU publications
Download
Order
Vacunas contra la COVID-19
¿cómo se desarrollan, autorizan y comercializan?
Latest edition .
Publication metadata
Debido a la urgencia de la pandemia, se están desarrollando y autorizando vacunas contra la COVID-19 más rápidamente de lo habitual. No obstante, esas vacunas cumplirán las mismas normas estrictas que todas las demás.
Download and languages
Close
Available languages and formats
Download
X
Available languages and formats
Bulgarian
(bg)
pdf
Spanish
(es)
pdf
Czech
(cs)
pdf
Danish
(da)
pdf
German
(de)
pdf
Estonian
(et)
pdf
Greek
(el)
pdf
English
(en)
pdf
French
(fr)
pdf
Irish
(ga)
pdf
Croatian
(hr)
pdf
Italian
(it)
pdf
Latvian
(lv)
pdf
Lithuanian
(lt)
pdf
Hungarian
(hu)
pdf
Maltese
(mt)
pdf
Dutch
(nl)
pdf
Polish
(pl)
pdf
Portuguese
(pt)
pdf
Romanian
(ro)
pdf
Slovak
(sk)
pdf
Slovenian
(sl)
pdf
Finnish
(fi)
pdf
Swedish
(sv)
pdf
Publication details
Related publications
All editions
Published:
2020-12-22
Corporate author(s):
Directorate-General for Communication
(
European Commission
)
Themes:
Public health
Subject:
clinical trial
,
coronavirus disease
,
epidemic
,
market
,
medical research
,
public awareness campaign
,
public health
,
safety standard
,
vaccination
,
vaccine
PDF
ISSN
ISBN
978-92-76-26457-6
DOI
10.2775/808680
Catalogue number
NA-03-20-809-ES-N
PDF
ISBN
978-92-76-26457-6
DOI
10.2775/808680
Catalogue number
NA-03-20-809-ES-N
HTML
ISSN
ISBN
978-92-76-26435-4
DOI
10.2775/525124
Catalogue number
NA-03-20-809-ES-Q
HTML
ISBN
978-92-76-26435-4
DOI
10.2775/525124
Catalogue number
NA-03-20-809-ES-Q
Paper
ISSN
ISBN
978-92-76-26482-8
DOI
10.2775/562501
Catalogue number
NA-03-20-809-ES-C
Paper
ISBN
978-92-76-26482-8
DOI
10.2775/562501
Catalogue number
NA-03-20-809-ES-C
View more
View less
Publication Viewer
Document viewer
The document doesn't have a viewable format at this time
Go Back Widget
Back to list of results
